Browse > Article
http://dx.doi.org/10.3339/jkspn.2010.14.1.1

Slowing the Progression of Chronic Kidney Disease in Children and Adolescents  

Ha, Il-Soo (Department of Pediatrics, Seoul National University Children's Hospital Kidney Institute, Seoul National University Medical Research Center)
Choi, Yong (Department of Pediatrics, Inje University Haeundae Paik Hospital)
Publication Information
Childhood Kidney Diseases / v.14, no.1, 2010 , pp. 1-9 More about this Journal
Abstract
Slowing the progression of chronic kidney disease is much more important in children and adolescents with a relatively longer remaining life span. A practical way to assess the rate of progression of chronic kidney disease is to measure the change of GFR estimated by formulae. To slow the progression, hypertension and proteinuria have to be controlled strictly, and hypoplastic anemia must be treated with erythropoietin. If not contraindicated, ACE inhibitor or angiotensin receptor blocker is recommended with monitoring of the side effects. Trials to slow the progression should be commenced as soon as the chronic kidney disease is confirmed and needs to be continued until renal transplantation as long as residual renal function remains. An online system, the Korean Pediatric Chronic Kidney Disease Registry (http://pedcrf.or.kr/), provides tools that are useful in evaluation and management of the children and adolescents with chronic kidney diseases.
Keywords
Chronic kidney disease; Progression; Children; Adolescents;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Litwin, M. Risk factors for renal failure in children with non-glomerular nephropathies. Pediatr Nephrol 2004;19:178-86.   DOI   ScienceOn
2 Schwartz GJ, Munoz A, Schneider MF, Mak RH, Kaskel F, Warady BA, et al. New equations to estimate GFR in children with CKD. J Am Soc Nephrol 2009;20:629-37.   DOI   ScienceOn
3 Gonzalez CC, Bitsori M, Tullus K. Progression of chronic renal failure in children with dysplastic kidneys. Pediatr Nephrol 2007; 22:1014-20.   DOI   ScienceOn
4 Trachtman H, Christen E, Frank R, Rini J, Palestro C, Perelstein E, et al. Pilot Study of Mycophenolate Mofetil for Treatment of Kidney Disease due to Congenital Urinary Tract Disorders in Children. Am J Kidney Dis 2008;52:706-15.   DOI   ScienceOn
5 Guzzo I, Mancini E, Wafo SK, Rava L, Picca S. Residual renal function and nutrition in young patients on chronic hemodialysis. Pediatr Nephrol 2009;24:1391-7.   DOI   ScienceOn
6 Zappitelli M, Joseph L, Gupta IR, Bell L, Paradis G. Validation of child serum creatinine-based prediction equations for glomerular filtration rate. Pediatr Nephrol 2007;22:272-81.
7 Ardissino G, Testa S, Dacco V, Vigano S, Taioli E, Claris-Appiani A, et al. Proteinuria as a predictor of disease progression in children with hypodysplastic nephropathy. Data from the Ital Kid Project. Pediatr Nephrol 2004;19:172-7.   DOI   ScienceOn
8 Counahan R, Chantler C, Ghazali S, Kirkwood B, Rose F, Barratt TM. Estimation of glomerular filtration rate from plasma creatinine concentration in children. Arch Dis Child 1976;51:875-8.   DOI   ScienceOn
9 Bouvet Y, Bouissou F, Coulais Y, Seronie-Vivien S, Tafani M, Decramer S, et al. GFR is better estimated by considering both serum cystatin C and creatinine levels. Pediatr Nephrol 2006;21:1299-306.   DOI   ScienceOn
10 Filler G, Lepage N. Should the Schwartz formula for estimation of GFR be replaced by cystatin C formula? Pediatr Nephrol 2003;18:981-5.   DOI   ScienceOn
11 Zappitelli M, Parvex P, Joseph L, Paradis G, Grey V, Lau S, et al. Derivation and validation of cystatin C-based prediction equations for GFR in children. Am J Kidney Dis 2006;48:221-30.   DOI   ScienceOn
12 Soares CM, Diniz JS, Lima EM, Oliveira GR, Canhestro MR, Colosimo EA, et al. Predictive factors of progression to chronic kidney disease stage 5 in a predialysis interdisciplinary programme. Nephrol Dial Transplant 2009;24:848-55.
13 Wuhl E, Trivelli A, Picca S, Litwin M, Peco-Antic A, Zurowska A, et al. Strict blood pressure control and progression of renal failure in children. N Engl J Med 2009;361: 1639-50.   DOI   ScienceOn
14 NKF. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002;39(Suppl 1):S1-266.
15 Schwartz GJ, Haycock GB, Edelmann CM, Spitzer A. A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine. Pediatrics 1976;58:259-63.
16 Mitsnefes M, Ho PL, McEnery PT. Hypertension and progression of chronic renal insufficiency in children: a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). J Am Soc Nephrol 2003;14:2618-22.   DOI   ScienceOn
17 Furth SL, Cole SR, Fadrowski JJ, Gerson A, Pierce CB, Chandra M, et al. The association of anemia and hypoalbuminemia with accelerated decline in GFR among adolescents with chronic kidney disease. Pediatr Nephrol 2007;22:265-71.
18 Levin A. The advantage of a uniform terminology and staging system for chronic kidney disease (CKD). Nephrol Dial Transplant 2003;18:1446-51.   DOI
19 Perkins RM, Aboudara MC, Uy AL, Olson SW, Cushner HM, Yuan CM. Effect of pentoxifylline on GFR decline in CKD: a pilot, double-blind, randomized, placebo-controlled trial. Am J Kidney Dis 2009;53:606-16.   DOI   ScienceOn
20 Iida S, Kohno K, Yoshimura J, Ueda S, Usui M, Miyazaki H, et al. Carbonic-adsorbent AST-120 reduces overload of indoxyl sulfate and the plasma level of TGF-beta1 in patients with chronic renal failure. Clin Exp Nephrol 2006;10:262-7.   DOI   ScienceOn
21 Shemin D, Bostom AG, Lambert C, Hill C, Kitsen J, Kliger AS. Residual renal function in a large cohort of peritoneal dialysis patients: change over time, impact on mortality and nutrition. Perit Dial Int 2000;20:439-44.
22 Wuehl E, Mehls O, Schaefer F. ESCAPE Trial Group: Long-term dissociation of antiproteinuric and antihypertensive efficacy of ACE inhibition in children with chronic renal failure. COD.OC 16 [Abstract] Pediatr Nephrol 2006;21:1505.
23 Ardissino G, Vigano S, Testa S, Dacco V, Paglialonga F, Leoni A, et al. No clear evidence of ACEi efficacy on the progression of chronic kidney disease in children with hypodysplastic nephropathy--report from the ItalKid Project database. Nephrol Dial Transplant 2007;22:2525-30.   DOI   ScienceOn
24 The GISEN Group (Gruppo Italiano di Studi Epidemiologici in Nefrologia). Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. Lancet 1997; 349:1857-63.   DOI
25 Litwin M, Grenda R, Sladowska J, Antoniewicz J. Add-on therapy with angiotensin II receptor 1 blocker in children with chronic kidney disease already treated with angiotensin-converting enzyme inhibitors. Pediatr Nephrol 2006;21:1716-22.   DOI   ScienceOn
26 Fried LF, Orchard TJ, Kasiske BL. Effect of lipid reduction on the progression of renal disease: a meta-analysis. Kidney Int 2001; 59:260-9.   DOI   ScienceOn
27 Gooch K, Culleton BF, Manns BJ, Zhang J, Alfonso H, Tonelli M, et al. NSAID use and progression of chronic kidney disease. Am J Med 2007;120:270 e1-7.
28 Klahr S, Levey AS, Beck GJ, Caggiula AW, Hunsicker L, Kusek JW, et al. The effects of dietary protein restriction and bloodpressure control on the progression of chronic renal disease. Modification of Diet in Renal Disease Study Group. N Engl J Med 1994;330:877-84.   DOI   ScienceOn
29 Chaturvedi S, Jones C. Protein restriction for children with chronic renal failure. Cochrane Database Syst Rev 2007;17:CD006863.
30 Gouva C, Nikolopoulos P, Ioannidis JP, Siamopoulos KC. Treating anemia early in renal failure patients slows the decline of renal function: a randomized controlled trial. Kidney Int 2004;66:753-60.   DOI   ScienceOn
31 Liu KP, Lin CY, Chen, HJ, Wei CF, Lee-Chen GJ. Renin-angiotensin system polymorphisms in Taiwanese primary vesicoureteral reflux. Pediatr Nephrol 2004;19: 594-601.   DOI   ScienceOn
32 Han KH, Lee SH, Lee HK, Choi HJ, Lee BH, Cho HY, et al. Risk factors for the progression of pediatric chronic kidney disease - a single center study. J Korean Soc Pediatr Nephrol 2007;11:239-246.   과학기술학회마을   DOI
33 Schwarz S, Trivedi BK, Kalantar-Zadeh K, Kovesdy CP. Association of disorders in mineral metabolism with progression of chronic kidney disease. Clin J Am Soc Nephrol 2006;1:825-31.   DOI   ScienceOn
34 Lee-Chen GJ, Liu KP, Lai YC, Juang HS, Huang SY, Lin CY. Significance of the tissue kallikrein promoter and transforming growth factor-beta1 polymorphisms with renal progression in children with vesicoureteral reflux. Kidney Int 2004;65:1467-72.   DOI   ScienceOn
35 Kawaguchi H, Hattori M, Ito K. Somatic and renal effects of growth hormone in rats with chronic renal failure. Pediatr Nephrol 1997; 11:280-4.   DOI   ScienceOn
36 Wong CS, Pierce CB, Cole SR, Warady BA, Mak RH, Benador NM, et al. Association of proteinuria with race, cause of chronic kidney disease, and glomerular filtration rate in the chronic kidney disease in children study. Clin J Am Soc Nephrol 2009;4:812-9.   DOI   ScienceOn
37 Mehls O, Broyer M. Growth response to recombinant human growth hormone in short prepubertal children with chronic renal failure with or without dialysis. The European/Australian Study Group. Acta Paediatr Suppl 1994;399:81-7.
38 Soares CM, Diniz JS, Lima EM, Silva JM, Oliveira GR, Canhestro MR, et al. Clinical outcome of children with chronic kidney disease in a pre-dialysis interdisciplinary program. Pediatr Nephrol 2008;23:2039-46.   DOI   ScienceOn
39 Hohenfellner K, Wingen AM, Nauroth O, Wuhl E, Mehls O, Schaefer F. Impact of ACE I/D gene polymorphism on congenital renal malformations. Pediatr Nephrol 2001;16: 356-61.   DOI   ScienceOn
40 Lane PH. Puberty and chronic kidney disease. Adv Chronic Kidney Dis 2005;12: 372-7.   DOI   ScienceOn
41 Tonshoff B, Fine RN. Recombinant human growth hormone for children with renal failure. Adv Ren Replace Ther 1996;3:37-47.   DOI